Block copolymer micelles as vehicles for drug delivery
暂无分享,去创建一个
Yokoyama Masayuki | Sakurai Yasuhisa | Kataoka Kazunori | S Kwon Glenn | Okano Teruo | Yokoyama Masayuki | Sakurai Yasuhisa | O. Teruo | Kataoka Kazunori | S. Glenn | Kwon Glenn S.
[1] T. Okano,et al. Molecular design for missile drug: Synthesis of adriamycin conjugated with immunoglobulin G using poly(ethylene glycol)-block-poly(aspartic acid) as intermediate carrier , 1989 .
[2] J. Baldrián,et al. Small‐angle X‐ray scattering of the block copolymer polystyrene/polybutadiene/polystyrene in ethyl methyl ketone , 1973 .
[3] F. Formelli,et al. Pharmacokinetics of 4'-deoxy-4'-iodo-doxorubicin in plasma and tissues of tumor-bearing mice compared with doxorubicin. , 1987, Cancer research.
[4] J. Feijen,et al. OPTIMIZATION OF MACROMOLECULAR PRODRUGS OF THE ANTITUMOR ANTIBIOTIC ADRIAMYCIN , 1985 .
[5] H. Ringsdorf,et al. Micelle-forming block copolymers: Pinocytosis by macrophages and interaction with model membranes , 1985 .
[6] M. Winnik,et al. Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers , 1990 .
[7] T. Okano,et al. Preparation of micelle-forming polymer-drug conjugates. , 1992, Bioconjugate chemistry.
[8] K. N. Prasad,et al. Surface activity and association of ABA polyoxyethylene—polyoxypropylene block copolymers in aqueous solution , 1979 .
[9] T. Okano,et al. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. , 1990, Cancer research.
[10] A. Florence,et al. Poloxamer association in aqueous solution , 1982 .
[11] T. Okano,et al. Blood compatibility of PEO grafted polyurethane and HEMA/styrene block copolymer surfaces. , 1990, Journal of biomedical materials research.
[12] K. Kataoka,et al. Synthesis and permeation behavior of membranes from segmented multiblock copolymers containing poly(ethylene oxide) and poly(β‐benzyl L‐aspartate) blocks , 1990 .
[13] N. Dimmock,et al. Introduction to Modern Virology , 1974 .
[14] K. Abe,et al. Interactions Between Macromolecules in Solution and Intermacromolecular Complexes , 1982 .
[15] N. Melik-Nubarov,et al. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles , 1989, FEBS letters.
[16] F. Davis,et al. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.
[17] S. Carter. Adriamycin-a review. , 1975, Journal of the National Cancer Institute.
[18] R. Xu,et al. Micellization of polystyrene-poly(ethylene oxide) block copolymers in water. 5. A test of the star and mean-field models , 1992 .
[19] Joseph D. Andrade,et al. Protein—surface interactions in the presence of polyethylene oxide , 1991 .
[20] H. Ringsdorf,et al. Watersoluble polymers in medicine , 1984 .
[21] R. Counsell,et al. Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents. , 1982, Journal of medicinal chemistry.
[22] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[23] S. Tsukagoshi,et al. Synthesis of antitumor‐active conjugates of adriamycin or daunomycin with the copolymer of divinyl ether and maleic anhydride , 1986 .
[24] M. Vert. Polyvalent polymeric drug carriers. , 1986, Critical reviews in therapeutic drug carrier systems.
[25] Yokoyama Masayuki,et al. Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer , 1990 .
[26] R. Kjellander,et al. Water structure and changes in thermal stability of the system poly(ethylene oxide)–water , 1981 .
[27] R. Xu,et al. Light-scattering study of the association behavior of styrene-ethylene oxide block copolymers in aqueous solution , 1991 .
[28] H. Maeda,et al. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. , 1984, Cancer research.
[29] P. Bahadur,et al. Interaction studies of styrene-ethylene oxide block copolymers with ionic surfactants in aqueous solution , 1988 .
[30] G. Poste. Drug Targeting in Cancer Therapy , 1984 .
[31] A. Halperin. Polymeric micelles: a star model , 1987 .
[32] P. Kratochvíl,et al. Block and graft copolymer micelles in solution , 1976 .
[33] H. Wada,et al. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol. , 1981, The Journal of pharmacology and experimental therapeutics.
[34] Benjamin Chu,et al. Light-scattering study on the association behavior of triblock polymers of ethylene oxide and propylene oxide in aqueous solution , 1988 .
[35] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[36] F. Zunino,et al. Comparative distribution of free doxorubicin and poly-L-aspartic acid linked doxorubicin in MS-2 sarcoma bearing mice. , 1986, Cancer drug delivery.
[37] K. Kataoka,et al. Preparation of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. A new type of polymeric anticancer agent , 1987 .
[38] J. Kopeček. Targetable Polymeric Anticancer Drugs , 1991, Annals of the New York Academy of Sciences.
[39] J. Cummings,et al. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS). , 1986, European journal of cancer & clinical oncology.
[40] Nicholas J. Turro,et al. Photoluminescent Probes for Water-Soluble Polymers. Pressure and Temperature Effects on a Polyol Surfactant, , 1984 .
[41] E. P. Denine,et al. Comparative pharmacokinetics of daunomycin and adriamycin in several animal species. , 1972, Cancer research.
[42] A. Abuchowski,et al. The clinical efficacy of poly(ethylene glycol)-modified proteins , 1990 .
[43] T. Okano,et al. Stabilization of disulfide linkage in drug-polymer-immunoglobulin conjugate by microenvironmental control. , 1989, Biochemical and biophysical research communications.
[44] J. Feijen,et al. Synthesis, Characterization and Antitumor Activity of Macromolecular Prodrugs of Adriamycin , 1984 .
[45] S. Rajagopalan,et al. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance. , 1989, Cancer research.
[46] Y. Yokota,et al. Hydrated Dynamic Surfaces , 1987 .
[47] I. R. Schmolka. A review of block polymer surfactants , 1977 .
[48] C. Ganote,et al. The effect of Pluronic F-38 (Polyoxamer 108) administered intravenously to rats. , 1978, Toxicology and applied pharmacology.
[49] T. Okano,et al. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.
[50] H. Ringsdorf,et al. Polymeric Antitumor Agents on a Molecular and on a Cellular Level , 1981 .
[51] Mitchell A. Winnik,et al. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study , 1991 .